Is DSIP FDA-approved?

Not in the US. DSIP (emideltide) isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.

Checked 25 Oct 2026. The sources are below.

DSIP

Also: delta sleep-inducing peptide, emideltide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

Status label in the Peptimes Library
Approved outside the US
Routes in Peptimes
SubcutaneousNasalOther
Updated
25 Oct 2026

US regulatory status

  • FDA status

    Not FDA-approved in the US. Drugs@FDA lists no application with emideltide (DSIP) as an active ingredient.

    Source: Drugs@FDA, checked 25 Oct 2026

How to track it in Peptimes

Add DSIP in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Approved outside the US”. In the US it is not FDA-approved.

  • Routes: subcutaneous, nasal or Other. Choose the one that matches each dose.
  • Logging: the amount you took, the route and how you feel.
  • Injection sites: subcutaneous doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Nasal doses and doses logged as Other skip this step.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell DSIP or any other compound.

More sources

  • FDA, Global Substance Registration System, Emideltide, checked 25 Oct 2026: its sequence of 9 amino acids, and the names emideltide, delta sleep-inducing peptide and DSIP.

Coming soon to the App Store

See planned pricing